Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Corbus Pharmaceuticals Holdings Inc
Total Current Liabilities
Corbus Pharmaceuticals Holdings Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
|
Total Current Liabilities
$31.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
12%
|
CAGR 10-Years
49%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Current Liabilities
$41.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Current Liabilities
$13B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Liabilities
$19.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Current Liabilities
$3.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
28%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Current Liabilities
$3.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
28%
|
See Also
What is Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities?
Total Current Liabilities
31.9m
USD
Based on the financial report for Dec 31, 2023, Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities amounts to 31.9m USD.
What is Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
49%
Over the last year, the Total Current Liabilities growth was 153%.